Clinical trialNCT07030257RecruitingPhase 1/PHASE2Interventional

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

SponsorTasca TherapeuticsEnrollment150Bladder CancerColorectal CarcinomaHead and Neck (HNSCC)Non-Small Cell Lung CancerPancreatic Cancer, Advanced or MetastaticSmall Cell Lung Cancer ( SCLC )+1 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Sarah Cannon Research Institute at Healthone
Denver, Colorado, United States
Gerald Falchook, MD
Recruiting
Florida Cancer Specialists-Lake Nona
Orlando, Florida, United States
Cesar Perez, MD
Recruiting
Start Midwest
Grand Rapids, Michigan, United States
Sreenivasa Chandana, MD
Recruiting
Washington University
St Louis, Missouri, United States
Nikolaos Trikalinos, MD
Recruiting
Nebraska Cancer Specialists
Omaha, Nebraska, United States
Ralph Hauke, MD
Recruiting
Carolina Biooncology Institute
Huntersville, North Carolina, United States
Neel Gandhi, MD
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Alex Adjei, MD
Recruiting
Taylor Cancer Research Center
Maumee, Ohio, United States
Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Roger Cohen, MD
Recruiting
Next Oncology - Dallas
Dallas, Texas, United States
Michael Song, MD, PhD, PharmD
Recruiting
Start San Antonio
San Antonio, Texas, United States
Kyriakos P. Papadopoulos, MD
Recruiting
Start Mountain Region
West Valley City, Utah, United States
William McKean, MD, PhD
Recruiting
Next Virginia
Fairfax, Virginia, United States
Alexander Spira, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CP-383

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 27 Aug 2025
Primary completion: 15 Aug 2028
Completion: 28 Feb 2029
Last update posted: 18 Feb 2026
Registered enrollment: 150
Registry id: NCT07030257

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.